(Press-News.org) University of Leeds researchers, funded by Cancer Research UK, have used a library of DNA to create a vaccine that could be used to treat cancer, according to a study published in Nature Medicine.
Before now, 'gene therapy' vaccines have often delivered just one gene to stimulate the immune system. It produces a protein, called an antigen, which activates the immune system to destroy cancer cells.
It has been difficult to develop successful cancer vaccines because each tumour has specific proteins and identifying the right antigens has been a huge challenge.
Scientists have also tried to boost the effectiveness of vaccines by using several genes to increase the chances of producing successful antigens. But a worry has always been that the immune system's response would be too strong for the body to handle.
But now researchers, working with the Mayo Clinic in Rochester, US, have solved this problem in experiments involving mice.
The team used doses of a vaccine made from a virus which contained a 'library' of DNA, containing multiple fragments of genes and therefore many possible antigens. This approach did not send the immune system into overdrive, which had been a concern. Instead the range of DNA meant the vaccine was able to target the tumour through many routes.
Importantly, the DNA library was harvested from the same organ as the tumour. This meant that the immune system 'self-selected' the cancer antigens to respond to and did not react against other healthy parts of the body. Also, the process of self-selection was triggered when the vaccine was injected into the bloodstream, an approach to vaccination that is far more practical than injecting directly into tumours.
The researchers delivered a library of DNA taken from healthy prostate tissue in mice. When delivered in a virus, the vaccine successfully treated mice with prostate cancer.
University of Leeds' Professor Alan Melcher, co-author of the study, said: "This is the first time we've been able to use a whole library of DNA in a viral vaccine successfully.
"The biggest challenge in immunology is developing antigens that can target the tumour without causing harm elsewhere.
"By using DNA from the same part of the body as the tumour, inserted into a virus, we may be able to solve that problem."
The vaccine was made by putting the DNA library inside a vesicular stomatitis virus (VSV), which stimulates an immune response that can then track down and kill tumour cells.
Professor Peter Johnson, Cancer Research UK's chief clinician, said: "This is an interesting and significant study which could really broaden out the field of immunotherapy research.
"Although the vaccine didn't trigger the immune system to overreact and cause serious side effects in mice, it will need to be further developed and tested in humans before we can tell whether this technique could one day be used to treat cancer patients."
INFORMATION:
The study was funded by the US National Institutes of Health, Cancer Research UK, The Richard M. Schulze Family Foundation, Mayo Clinic, and a private grant.
For more information:
Contact: Paula Gould, University of Leeds Communications & Press Office: Tel +44 (0)113 343 8059, email p.a.gould@leeds.ac.uk
Notes to editors:
1. A copy of the paper is available on request (Broad Antigenic Coverage Induced by Viral cDNA Library-based Vaccination Cures Established Tumors. Kottke et al. Nature Medicine. 19 June 2011. DOI 10.1038/nm.2390).
2. Listen to Professor Alan Melcher talking about the research here: http://streamservice.sc-streaming.com/backend/previewCam.aspx?camID=272_29325&width=135&height=60
3. One of the UK's largest medical, health and bioscience research bases, the University of Leeds delivers world leading research in medical engineering, cancer, cardiovascular studies, epidemiology, molecular genetics, musculoskeletal medicine, dentistry, psychology and applied health. Treatments and initiatives developed in Leeds are transforming the lives of people worldwide with conditions such as diabetes, HIV, tuberculosis and malaria. www.leeds.ac.uk
4. Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research.
The charity's groundbreaking work into the prevention, diagnosis and treatment of cancer has helped save millions of lives. This work is funded entirely by the public.
Cancer Research UK has been at the heart of the progress that has already seen survival rates double in the last forty years.
Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
Together with its partners and supporters, Cancer Research UK's vision is to beat cancer.
For further information about Cancer Research UK's work or to find out how to support the charity, please call 020 7121 6699 or visit www.cancerresearchuk.org
END
New Haven, Conn. — A single gene is central in the development of several forms of polycystic kidney and liver disease, Yale School of Medicine researchers report in the June 19 issue of Nature Genetics.
The findings suggest manipulating activity of PKD1, the gene causing the most common form of polycystic kidney disease, may prove beneficial in reducing cysts in both liver and kidney.
"We found that these conditions are not the result of an all or nothing phenomenon," said Stefan Somlo, the C.N.H. Long Professor of Medicine and Genetics and Chief, Section of Nephrology ...
More and more now, the IRS officers who pursue back taxes are becoming aggressive and inflexible, demanding payments from taxpayers without regard for their personal situation.
Pamela (Fresno, CA) was feeling the pinch from an IRS Revenue Officer who was hammering her to make a payment on the approximately $11,000 she owed to the IRS. At her wits' end, she contacted Blue Tax.
The Blue Tax team interviewed Pamela and discovered that the Revenue Officer had given her a deadline to make a $200 payment. They were also able to ascertain that she indeed would be unable ...
SEATTLE – Researchers at Fred Hutchinson Cancer Research Center have demonstrated in mice that the performance of a novel biomarker-development pipeline using targeted mass spectrometry is robust enough to support the use of an analogous approach in humans. The findings, by principal investigator Amanda Paulovich, M.D., Ph.D., an associate member of the Hutchinson Center's Clinical Research Division, are published in Nature Biotechnology.
Paulovich and colleagues demonstrated that a staged, targeted pipeline approach using mass spectrometry to prioritize and validate proteins ...
Boston, MA (June 19, 2011)—Mitochondria, those battery-pack organelles that fuel the energy of almost every living cell, have an insatiable appetite for calcium. Whether in a dish or a living organism, the mitochondria of most organisms eagerly absorb this chemical compound. Because calcium levels link to many essential biological processes—not to mention conditions such as neurological disease and diabetes—scientists have been working for half a century to identify the molecular pathway that enables these processes.
After decades of failed effort that relied on classic ...
Evans Consoles is pleased to announce they have been chosen as the recipients of the 2011 Best of NeoCon "Innovation" Award, in the "Furniture Workstation Tables" category. Evans products were well received at NeoCon 2011, which is widely considered the "Premier North American event for Interior Design and Facilities Management."
The ultimate open architecture solution for maximum sightlines and functionality, Evans' Strategy console has been specifically designed for technology-intensive, 24/7 environments. Strategy offers flexible equipment ...
Breast cancer accounts for almost a third of all cancer cases reported in women. However advances in the treatment for breast cancer, and early detection, have improved the chances of survival from the disease. New research published in BioMed Central's open access journal Breast Cancer Research has found that two thirds of women with breast cancer died from other causes and that over the length of the study cardiovascular disease was the leading cause of death.
Breast cancer is now the most common cancer in the UK affecting one in eight women with eight out of ten of ...
Loss of muscle mass is not only associated with disease, such as HIV and cancer, but also with the normal aging process. Anabolic steroids are sometimes used to reverse loss of lean muscle tissue but they can have unwanted side effects. New research, published in BioMed Central's open access journal Immunity and Aging, shows that nine proteins, isolated from blood, alter with age and that the profile of some of these proteins can be reversed by testosterone treatment.
In a combined study, researchers from Boston University School of Medicine and University of Texas Medical ...
Designing new materials depends upon understanding the properties of today's materials. One such material, Nafion ©, is a polymer that efficiently conducts ions (a polymer electrolyte) and water through its nanostructure, making it important for many energy-related industrial applications, including in fuel cells, organic batteries, and reverse-osmosis water purification. But since Nafion was invented 50 years ago, scientists have only been able to speculate about how to build new materials because they have not been able to see details on how the molecules come together ...
Heavy and prolonged snowfall can bring about unexpected conditions that encourage fungal growth, leading to the death of plants in the Arctic, according to experts.
A new international study confirms that whilst snow has an insulating effect which helps plants to grow bigger, heavy and prolonged snow can, in certain circumstances, also encourage the rapid and extensive growth of killer fungal strains.
The research results, published in the journal Nature Climate Change, show for the first time the potential long term effects of unexpected fungal development on an arctic ...
Climate change disasters, such as the melting of the Greenland ice sheet, dieback of the Amazon rainforest or collapse of the Atlantic overturning circulation, could be predicted according to University of Exeter research.
Writing in the journal Nature Climate Change, Professor Tim Lenton of the University of Exeter shows that the 'tipping points' that trigger these disasters could be anticipated by looking for changes in climate behaviour.
Climate 'tipping points' are small changes that trigger a massive shift in climate systems, with potentially devastating consequences. ...
